Russell Investments Group
TYRA icon

Russell Investments Group’s Tyra Biosciences TYRA Stock Holding History

Russell Investments Group’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.7M Buy
70,422
+57,426
+442% +$1.86M ﹤0.01% 1705
2025
Q4 		$342K Buy
12,996
+255
+2% +$4.68K ﹤0.01% 2629
2025
Q3 		$178K Buy
12,741
+2,766
+28% +$31.5K ﹤0.01% 2848
2025
Q2 		$95.5K Sell
9,975
-264
-3% -$2.51K ﹤0.01% 2828
2025
Q1 		$95.2K Sell
10,239
-216
-2% -$2.79K ﹤0.01% 2769
2024
Q4 		$145K Buy
10,455
+10,447
+130,588% +$190K ﹤0.01% 2610
2024
Q3 		$188 Hold
8
– – ﹤0.01% 3639
2024
Q2 		$128 Sell
8
-118
-94% -$2.03K ﹤0.01% 3558
2024
Q1 		$2.07K Buy
126
+107
+563% +$1.75K ﹤0.01% 3069
2023
Q4 		$263 Hold
19
– – ﹤0.01% 3165
2023
Q3 		$262 Sell
19
-157
-89% -$2.33K ﹤0.01% 3458
2023
Q2 		$3K Buy
+176
New +$2.55K ﹤0.01% 3183

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Russell Investments Group's TYRA Position: Q1 2026 in Review

Russell Investments Group increased its Tyra Biosciences (TYRA) stake by 442% in Q1 2026, buying an estimated $1.86M and bringing the position to 70,422 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1705.

Russell Investments Group first reported a position in TYRA in Q2 2023 and has held it in 12 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Russell Investments Group held 70,422 shares of Tyra Biosciences worth $2.7M as of Q1 2026.
  • Russell Investments Group bought 57,426 Tyra Biosciences shares in Q1 2026, an estimated $1.86M.
  • Tyra Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #1705 holding.
  • Russell Investments Group first reported a position in Tyra Biosciences in Q2 2023 and has held it in 12 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.